Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them
The World’s Deadliest Diseases: How is Biotech Fighting Them?
Interview with Francis Mojica, the Spanish Scientist that Discovered CRISPR
Can this French Biotech Make it Easier to Rescue People from Hypoglycemia?
German Biotech Reels in €34M for its Cancer-Killing Technology
French Biotech Steps Up Autoimmune Disease Drug Development with €14.5M Series A
French Biotech Launches €30M IPO to be the First to Treat Rare Disease in Children
Welcome to Amsterdam, EMA! Your New Home Post-Brexit
The Lowdown on Biotech Salaries: 10 Steps on the European Ladder
Roche’s Potential Hemophilia Blockbuster and Lung Cancer Drug Succeed in the Clinic
British and German Scientists Chuck Proteins in the Trash to Uncover their Function
After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy
Thinking of Leaving Academia? Read this VC Partner’s Story
Bacterial Art Starts a Debate on Money and International Borders
Welcome to the Blockbuster Club, Genmab!
+ More News
Labiotech Hires More Pink Stick Figures!
+ More on us
We Just Hit Refresh on Refresh!
+ More on refresh
BioFIT 2017– academia-industry collaborations in Life Sciences
Innovation Forum 2017 – Leaders Conference
December 4 to 09:00
December 5 to 21:00
Tumour Models London 2017
View All Events
+ All the planning
Labiotech UG, All Rights Reserved -
Send this to a friend